Home
>
Reference Standards>HCV>
>
1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-
For research use only. Not for therapeutic Use.
1-Pyrrolidinecarboxylic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-1H-imidazole-5,2-diyl)bis-, 1,1′-bis(1,1-dimethylethyl) ester, (2S,2’S)-(Cat No.:M000193)is a stereochemically defined biphenyl-imidazole derivative with potential applications in pharmaceutical and biochemical research. Its structure, featuring pyrrolidine and imidazole moieties, suggests roles in modulating enzymatic or receptor activities, making it valuable for investigating signaling pathways or drug-receptor interactions. The bulky tert-butyl ester groups enhance stability and solubility, facilitating its use in various experimental setups. This compound’s unique chemical framework supports its utility in the development of novel therapeutic agents or as a research tool in advanced medicinal chemistry.
Catalog Number | M000193 |
CAS Number | 1007882-23-6 |
Molecular Formula | C36H44N6O4 |
Purity | ≥95% |
Target | HCV |
IUPAC Name | tert-butyl (2S)-2-[5-[4-[4-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate |
InChI | InChI=1S/C36H44N6O4/c1-35(2,3)45-33(43)41-19-7-9-29(41)31-37-21-27(39-31)25-15-11-23(12-16-25)24-13-17-26(18-14-24)28-22-38-32(40-28)30-10-8-20-42(30)34(44)46-36(4,5)6/h11-18,21-22,29-30H,7-10,19-20H2,1-6H3,(H,37,39)(H,38,40)/t29-,30-/m0/s1 |
InChIKey | WPMTYMFNINZZHE-KYJUHHDHSA-N |
SMILES | CC(C)(C)OC(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)OC(C)(C)C |